| 000 | 01872 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516021137.0 | ||
| 264 | 0 | _c20110623 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1879-3177 | ||
| 024 | 7 |
_a10.1016/j.tiv.2010.12.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Wei-Chuan | |
| 245 | 0 | 0 |
_aEffect of diallyl disulfide on Ca2+ movement and viability in PC3 human prostate cancer cells. _h[electronic resource] |
| 260 |
_bToxicology in vitro : an international journal published in association with BIBRA _cApr 2011 |
||
| 300 |
_a636-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAllyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xchemistry |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCytosol _xdrug effects |
| 650 | 0 | 4 |
_aDisulfides _xpharmacology |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aFura-2 _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 700 | 1 | _aHsu, Shu-Shong | |
| 700 | 1 | _aChou, Chiang-Ting | |
| 700 | 1 | _aKuo, Chun-Chi | |
| 700 | 1 | _aHuang, Jong-Khing | |
| 700 | 1 | _aFang, Yi-Chien | |
| 700 | 1 | _aChang, Hong-Tai | |
| 700 | 1 | _aTsai, Jeng-Yu | |
| 700 | 1 | _aLiao, Wei-Chuan | |
| 700 | 1 | _aWang, Being-Whey | |
| 700 | 1 | _aShieh, Pochuen | |
| 700 | 1 | _aKuo, Daih-Huang | |
| 700 | 1 | _aJan, Chung-Ren | |
| 773 | 0 |
_tToxicology in vitro : an international journal published in association with BIBRA _gvol. 25 _gno. 3 _gp. 636-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tiv.2010.12.015 _zAvailable from publisher's website |
| 999 |
_c20515650 _d20515650 |
||